Lung Biofilms

Bacterial and fungal biofilms are a major factor in many pulmonary diseases and infections. Lung inflammation can range from pneumonia biofilm development to chronic infection from Pseudomonas aeruginosa in cystic fibrosis patients. These pathogens have the capabilities to invade the entire respiratory system.

With the BioFlux system, analysis of these biofilms is made easy. Customers have used the BioFlux for a wide array of lung biofilm assays, including the competition between bacterial strains and the discovery of novel anti-biofilm drugs.

F3.medium
A BioFlux system was used to analyze how bacterial strains compete in biofilms isolated from cystic fibrosis patients. Strains were labeled with mCherry and GFP. They found that toxic proteins called pyocins, specifically R-pyocins, play a large role in the competition between strains of P. aeruginosa (Oluyombo et al., 2019).
fmicb 05 00280 g005
P. aeruginosa (red) and S. aeureus (blue) were grown in BioFlux microfluidic plates, then were attacked by B. bacteriovorus. As shown in the graph, B. bacteriovorus interrupted biofilm growth for both strains over the course of 24 hours (Iebba et al., 2014).

Key BioFlux Advantages For Lung Biofilm Studies

FAQs:
Lung Biofilm Formation and Microbial Adhesion Using BioFlux

The BioFlux System provides a microfluidic platform that simulates airway shear stress and nutrient flow, making it ideal for modeling lung biofilm formation. It supports real-time imaging and controlled environmental conditions for studying microbial adhesion, colonization, and biofilm development.

The BioFlux enables the study of pulmonary biofilm formation by perfusing respiratory pathogens through microfluidic channels seeded with pulmonary cells or coated with relevant substrates. Under controlled shear stress, pathogens like Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia can be introduced while mimicking airway conditions.

The BioFlux integrates with fluorescence and phase contrast microscopy, enabling the visualization of biofilm formation, structure, and dispersal in real time. It supports high-resolution imaging of microbial communities under dynamic flow conditions.

Yes, the BioFlux is widely used to study biofilm-associated infections in chronic lung disease models. Its ability to simulate airway-like flow and support long-term microbial culture makes it ideal for investigating persistent infections and antibiotic resistance.

the BioFlux replicates the dynamic flow conditions of the lung environment, which are critical for accurate biofilm modeling. Unlike static assays, it allows for controlled shear stress, nutrient delivery, and real-time observation of biofilm growth and detachment.

The BioFlux offers well-plates embedded with microfluidic channels support the testing of multiple experimental conditions. This enables comparative studies of antimicrobial treatments, surface coatings, and microbial strains under flow.

The microfluidic channels of BioFlux plates can be coated with various bio-compatible substrates that mimic lung or mucosal surfaces. This supports targeted studies of pulmonary microbial adhesion and biofilm formation.

Yes, the BioFlux can be used to study the growth of anaerobic and facultative anaerobic lung pathogens. Its design allows for the delivery of gas conditions that support the growth of anaerobic or facultative anaerobic pathogens commonly found in the lung microenvironment.

FAQs:
Lung Biofilm Formation and Microbial Adhesion Using BioFlux

What microfluidic platform is suited for studying lung biofilm formation under flow in vitro?

The BioFlux System provides a microfluidic platform designed to simulate airway shear stress and nutrient flow, supporting studies of lung biofilm formation. It enables real-time imaging and controlled environmental conditions for investigating microbial adhesion, colonization, and biofilm development.

How can I study biofilm formation by respiratory pathogens like Pseudomonas aeruginosa?
The BioFlux enables the study of pulmonary biofilm formation by perfusing respiratory pathogens through microfluidic channels seeded with pulmonary cells or coated with relevant substrates. Under controlled shear stress, pathogens like Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia can be introduced while mimicking airway conditions.
What are the advantages of using the BioFlux over static biofilm assays for lung pathogens?
The BioFlux replicates the dynamic flow conditions of the lung environment, which are critical for accurate biofilm modeling. Unlike static assays, it allows for controlled shear stress, nutrient delivery, and real-time observation of biofilm growth and detachment.
How does BioFlux support multi-condition lung biofilm experiments?
The BioFlux offers well plates with embedded microfluidic channels that support testing of multiple experimental conditions — enabling comparative studies of antimicrobial treatments, surface coatings, and microbial strains under flow.
What substrates can be used to coat the microfluidic channels of BioFlux plates in pulmonary biofilm studies?
BioFlux microfluidic channels can be coated with a range of biocompatible substrates designed to mimic lung or mucosal surfaces, supporting targeted studies of pulmonary microbial adhesion and biofilm formation.
Is the BioFlux compatible with anaerobic or facultative anaerobic lung pathogens?
Yes. The BioFlux supports study of anaerobic and facultative anaerobic lung pathogens. Its dual-gas capability allows delivery of gas conditions that support the growth of oxygen-sensitive pathogens commonly found in lung microenvironments.

Contact Us

If you need support for a product, please submit a support request.